NCT07161219

Brief Summary

  • Primary Objective: To evaluate the effects of complementary exercise protocols in cardiac rehabilitation (CR), such as inspiratory muscle training (IMT), by assessing inspiratory muscle strength.
  • Secondary Objectives: To assess functional capacity, quality of life (QoL), and pulmonary function.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
45mo left

Started Dec 2025

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Dec 2025Dec 2029

First Submitted

Initial submission to the registry

March 21, 2025

Completed
6 months until next milestone

First Posted

Study publicly available on registry

September 8, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
4.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Expected
Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

Same day

First QC Date

March 21, 2025

Last Update Submit

September 18, 2025

Conditions

Keywords

heart failureinspiratory muscles training

Outcome Measures

Primary Outcomes (1)

  • Maximal inspiratory pressure

    1 year

Study Arms (2)

control group

NO INTERVENTION

intervention group

EXPERIMENTAL
Device: inspiratory muscle training

Interventions

inspiratory muscle training for intervention group

intervention group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Patient meeting the conditions of the permanent life support agreement following hospitalization for a cardiac condition such as: acute myocardial infarction; coronary surgery; therapeutic percutaneous endovascular intervention on the coronary arteries, under medical imaging guidance; therapeutic percutaneous endovascular intervention on the heart, under medical imaging guidance; surgery for congenital or acquired heart malformation; surgery for valvular lesion; heart transplantation; resistant angina (to be specified by detailed history, medical history, and technical examinations, justifying multidisciplinary care); cardiomyopathy with left ventricular dysfunction (to be specified by detailed history, medical history, and technical examinations, justifying multidisciplinary care).
  • Patient aged between 18 and 80 years.
  • Patient capable of giving informed consent.
  • Patient registered for permanent life support at the CuSL.
  • Patient capable of understanding instructions in French. - Patient with prior medical consent and clinically stable.

You may not qualify if:

  • \- Minor (\<18 years old).
  • Pregnant woman.
  • Patient unable to provide informed consent.
  • Patient with cognitive, neurological, or orthopedic limitations.
  • Patient with mobility or musculoskeletal difficulties incompatible with physical activity.
  • Clinical instability.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart DiseasesHeart Failure

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized control trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 21, 2025

First Posted

September 8, 2025

Study Start

December 1, 2025

Primary Completion

December 1, 2025

Study Completion (Estimated)

December 31, 2029

Last Updated

September 23, 2025

Record last verified: 2025-09